文献速递神经MR

MR成像衍生的氧代谢与新生血管特征用于胶质瘤分级和IDH基因突变检测

MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
PubMed 文献 · Radiology · 2016-12-13

本回顾性研究纳入83例病理证实的胶质瘤(WHO II-IV级),采用定量血氧水平依赖成像和血管构筑成像计算氧代谢与新生血管生物标志物图。低级别胶质瘤氧摄取分数增高(+18%),高级别胶质瘤氧摄取分数降低(III级-54%,IV级-49%),可清晰区分低级别与高级别胶质瘤(AUC=1)。微血管类型指标对III级与IV级鉴别诊断性能最高(AUC=0.782),脑氧代谢率对低级别胶质瘤IDH突变检测性能最高(AUC=0.818),微血管类型指标对高级别胶质瘤(AUC=0.854)及所有WHO级别(AUC=0.899)IDH突变检测性能最高。

要点

  • 低级别胶质瘤氧摄取分数较正常脑组织增高18%,高级别胶质瘤氧摄取分数降低(III级-54%,IV级-49%)。
  • 氧摄取分数可清晰区分低级别与高级别胶质瘤,AUC为1。
  • 微血管类型指标对III级与IV级胶质瘤鉴别诊断性能最高,AUC为0.782。

核心结论

  • MR成像衍生的氧代谢与新生血管特征可能有助于胶质瘤分级和IDH突变检测,仅需额外7分钟成像时间。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准并获得所有患者书面知情同意,纳入83例组织病理学证实的胶质瘤患者(WHO II-IV级),采用定量血氧水平依赖成像和血管构筑成像计算生物标志物图,以受试者工作特征分析评估诊断性能。

关键影像表现/征象

  • 低级别(WHO II级)胶质瘤显示氧摄取分数增高的区域(+18%,P < .001,n = 20)。
  • 间变性胶质瘤(WHO III级)和胶质母细胞瘤(WHO IV级)较正常脑组织氧摄取分数降低(分别为-54% [P < .001,n = 21]和-49% [P < .001,n = 41])。
  • 低级别胶质瘤伴IDH基因突变者脑氧代谢率降低(P = .037)。
  • III级胶质瘤伴IDH突变者微血管类型指标较IDH野生型显著增高(P = .013)。

诊断标准与关键数值

  • 氧摄取分数区分低级别与高级别胶质瘤的AUC为1。
  • 微血管类型指标区分III级与IV级胶质瘤的AUC为0.782。
  • 脑氧代谢率检测低级别胶质瘤IDH突变的AUC为0.818。
  • 微血管类型指标检测高级别胶质瘤IDH突变的AUC为0.854,检测所有WHO级别IDH突变的AUC为0.899。

临床应用与阅片要点

  • 氧摄取分数图可用于区分低级别与高级别胶质瘤。
  • 微血管类型指标有助于III级与IV级胶质瘤的鉴别。
  • 脑氧代谢率可用于低级别胶质瘤IDH突变检测,微血管类型指标可用于高级别及所有级别胶质瘤IDH突变检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To explore the diagnostic performance of physiological magnetic resonance (MR) imaging of oxygen metabolism and neovascularization activity for grading and characterization of isocitrate dehydrogenase (IDH) gene mutation status of gliomas. Materials and Methods This retrospective study had institutional review board approval; written informed consent was obtained from all patients. Eighty-three patients with histopathologically proven glioma (World Health Organization [WHO] grade II-IV) were examined with quantitative blood oxygen level-dependent imaging and vascular architecture mapping. Biomarker maps of neovascularization activity (microvessel radius, microvessel density, and microvessel type indicator [MTI]) and oxygen metabolism (oxygen extraction fraction [OEF] and cerebral metabolic rate of oxygen [CMRO2]) were calculated. Receiver operating characteristic analysis was used to determine diagnostic performance for grading and detection of IDH gene mutation status. Results Low-grade (WHO grade II) glioma showed areas with increased OEF (+18%, P < .001, n = 20), whereas anaplastic glioma (WHO grade III) and glioblastoma (WHO grade IV) showed decreased OEF when compared with normal brain tissue (-54% [P < .001, n = 21] and -49% [P < .001, n = 41], respectively). This allowed clear differentiation between low- and high-grade glioma (area under the receiver operating characteristic curve [AUC], 1) for the patient cohort. MTI had the highest diagnostic performance (AUC, 0.782) for differentiation between gliomas of grades III and IV among all biomarkers. CMRO2 was decreased (P = .037) in low-grade glioma with a mutated IDH gene, and MTI was significantly increased in glioma grade III with IDH mutation (P = .013) when compared with the IDH wild-type counterparts. CMRO2 showed the highest diagnostic performance for IDH gene mutation detection in low-grade glioma (AUC, 0.818) and MTI in high-grade glioma (AUC, 0.854) and for all WHO grades (AUC, 0.899) among all biomarkers. Conclusion MR imaging-derived oxygen metabolism and neovascularization characterization may be useful for grading and IDH mutation detection of gliomas and requires only 7 minutes of extra imaging time. © RSNA, 2016 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Stadlbauer A, Zimmermann M, Kitzwögerer M, et al. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas. Radiology. 2016. PMID: 27982759. doi:10.1148/radiol.2016161422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。